Literature DB >> 13066323

[Pharmacology and toxicology of a new class of compounds with laxative effect].

L SCHMIDT.   

Abstract

Keywords:  CATHARTICS

Mesh:

Substances:

Year:  1953        PMID: 13066323

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


× No keyword cloud information.
  9 in total

1.  THE USE OF BISACODYL SUPPOSITORIES IN PREPARATION FOR SIGMOIDOSCOPY.

Authors:  I L EVANS
Journal:  Gut       Date:  1964-06       Impact factor: 23.059

2.  [DEACETYLATION AND ABSORPTION OF PHENOLATED LAXATIVES].

Authors:  G FERLEMANN; W VOGT
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1965-04-29

3.  Use of bisacodyl in preparation of the bowels for a barium enema.

Authors:  J G SOWERBUTTS
Journal:  Gut       Date:  1960-06       Impact factor: 23.059

4.  [Water and electrolyte movement in the small intestine and colon under the influence of laxatives, a contribution to the clearing of their mechanism of action].

Authors:  W Forth; W Rummel; J Baldauf
Journal:  Naunyn Schmiedebergs Arch Pharmakol Exp Pathol       Date:  1966

5.  Colon cleansing regimens. A clinical study in 1200 patients.

Authors:  F T Fork; O Ekberg; G Nilsson; C Rerup; A Skinhøj
Journal:  Gastrointest Radiol       Date:  1982

6.  [Mode of action of bisacodyl (dulcolax) on isolated muscles of human colon (author's transl)].

Authors:  P Mitznegg; E Schubert; W Domschke; U Strunz; S Domschke; K Schwemmle; L Demling; F Heim
Journal:  Klin Wochenschr       Date:  1975-05-15

7.  The therapeutic usefulness of dulcolax (biśacodyl), a new nonpurgative laxative.

Authors:  D A DREILING; A FISCHL; O FERNANDEZ
Journal:  Am J Dig Dis       Date:  1959-04

8.  Bisacodyl (dulcolax) in proctology.

Authors:  R ARCHAMBAULT
Journal:  Can Med Assoc J       Date:  1959-07-01       Impact factor: 8.262

Review 9.  Bisacodyl: A review of pharmacology and clinical evidence to guide use in clinical practice in patients with constipation.

Authors:  Maura Corsetti; Sabine Landes; Robert Lange
Journal:  Neurogastroenterol Motil       Date:  2021-03-09       Impact factor: 3.598

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.